Press Release Database

Lost Money on Badger Meter, Inc. (BMI)? Contact Levi & Korsinsky Before ...

(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 17, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Badger Meter, Inc. (NYSE:BMI) securities. If you suffered a loss on your Badger Meter investment and would like to explore a potential recovery under the federal securities laws, Learn about Badger Meter Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against Badger ..

Recover Investment Losses: Class Action Initiated Against Via Transportation, ...

(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 17, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Via Transportation, Inc. (NYSE:VIA) securities. If you suffered a loss on your Via Transportation, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Via Transportation, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: This lawsuit is on behalf of a ..

Jonathan Pinkston Shares tips on Finding Balance in everyday life.

Jerome T. Murphy Launches the “Think First” Personal Pledge

Associated Plastic Surgeons & Med Spa Earns Five Kansas City Favorites Honors; Dr. Sheryl L. Young Named Favorite Doctor

APSKC earns gold awards for Favorite Cosmetic Surgery and Favorite Med Spa, silver for Favorite Dermatology and Favorite Medical Practice

Levi & Korsinsky Urges GRAIL, Inc. (GRAL) Shareholders to Act Before ...

(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 17, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired GRAIL, Inc. (NASDAQ:GRAL) securities. If you suffered a loss on your GRAIL investment and would like to explore a potential recovery under the federal securities laws, Learn about GRAIL Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against GRAIL, Inc. that seeks ..

Securities Class Action Lawsuit Filed Against Hub Group, Inc. (HUBG) ...

(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 17, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Hub Group, Inc. (NASDAQ:HUBG) securities. If you suffered a loss on your Hub Group, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Hub Group, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed ..

/C O R R E C T I O N -- Barrel Energy, Inc./

In the news release, Barrel Energy Inc. Announces Expansion of Happy Traps Division with New Corporate Offices and Operations Facility, issued 17-Jul-2026 by Barrel Energy, Inc. over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release...

Levi & Korsinsky Notifies ADMA Biologics, Inc. (ADMA) Shareholders ...

(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 17, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired ADMA Biologics, Inc. (NASDAQ:ADMA) securities. If you suffered a loss on your ADMA Biologics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about ADMA Biologics, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed ..

Recover Investment Losses: Class Action Initiated Against Microsoft ...

(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 17, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Microsoft Corporation (NASDAQ:MSFT) securities. If you suffered a loss on your Microsoft Corporation investment and would like to explore a potential recovery under the federal securities laws, Learn about Microsoft Corporation Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against Microsoft Corporation ..

Securities Lawsuit Alert: Nano-X Imaging Ltd. (NNOX) - Contact Levi ...

(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 17, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Nano-X Imaging Ltd. (NASDAQ:NNOX) securities. If you suffered a loss on your Nano-X Imaging Ltd. investment and would like to explore a potential recovery under the federal securities laws, Learn about Nano-X Imaging Ltd. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed ..

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SAN CARLOS, Calif., July 17, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced that on July 16, 2026 (the “Date of Grant”), the Company approved the grant of inducement stock options covering an aggregate of 139,930 shares of Iovance’s common stock to seventeen new, non-executive employees.